Catalyst Wire Dossier Catalyst Wire Dossier

albuvirtide

albuvirtide · Frontier Biotechnologies Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for albuvirtide, covering 2021-03-26 to 2021-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Test Albuvirtide in Experienced Patients [Phase 3]

See pricing